SCHEMBL26468487

SCHEMBL26468487

CCCC(=O)C1=C(O)C(CC=C(C)C)=C(O)C(CC=C(C)C)(CC=C(C)C)C1=O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 2/20 0.55
▸ KDM4E B2RXH2 2/20 0.55
▸ MEN1 O00255 2/20 0.55
▸ KMT2A Q03164 2/20 0.55
▸ AKR1B10 O60218 1/20 0.55
▸ FASN P49327 8/20 0.46
▸ PTPN1 P18031 2/20 0.41
▸ ACHE P22303 1/20 0.35
▸ CYP3A4 P08684 2/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ TP53 P04637 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ PKM P14618 1/20 0.33
▸ CDC25A P30304 1/20 0.33
▸ CDC25B P30305 1/20 0.33
▸ RPS6KA3 P51812 1/20 0.33
▸ DHODH Q02127 1/20 0.33
▸ GLO1 Q04760 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ GPR35 Q9HC97 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31576822 0.93 ALOX5 (0.53) ALOX5KDM4EMEN1KMT2AAKR1B10
SCHEMBL29405771 0.90 ALOX5 (0.57) ALOX5KDM4EMEN1KMT2AAKR1B10
SCHEMBL23155161 0.86 ALOX5 (0.61) ALOX5KDM4EMEN1KMT2AAKR1B10
SCHEMBL26468494 0.86 ALOX5 (0.74) ALOX5KDM4EMEN1KMT2AAKR1B10
SCHEMBL31576807 0.85 MEN1 (0.54) ALOX5KDM4EMEN1KMT2AAKR1B10
SCHEMBL819253 0.84 ALOX5 (0.78) ALOX5KDM4EMEN1KMT2AAKR1B10
SCHEMBL30959751 0.83 ALOX5 (0.63) ALOX5KDM4EMEN1KMT2AAKR1B10
SCHEMBL13922241 0.83 ALOX5 (0.52) ALOX5KDM4EMEN1KMT2AAKR1B10
SCHEMBL817774 0.80 ALOX5 (0.53) ALOX5KDM4EMEN1KMT2AAKR1B10
SCHEMBL24734305 0.79 ALOX5 (0.55) ALOX5KDM4EMEN1KMT2AAKR1B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025104281-A1 HOP DERIVED COMPOUNDS FOR USE IN THE TREATMENT OF DISEASES CAUSED BY CORONAVIRUSES CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2025-05-22 — — WO disclosed
EP-4556004-A1 HOP DERIVED COMPOUNDS FOR USE IN THE TREATMENT OF DISEASES CAUSED BY CORONAVIRUSES Centre National de la Recherche Scientifique (FR) 2025-05-21 — — EP disclosed
US-20230138884-A1 HUMULUS SPECIES AS INDUSTRIAL CHEMICAL FEEDSTOCKS P2 SCIENCE, INC. 2023-05-04 — — US disclosed
US-20230138884-A1 HUMULUS SPECIES AS INDUSTRIAL CHEMICAL FEEDSTOCKS P2 SCIENCE, INC. 2023-05-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230138884-A1 HUMULUS SPECIES AS INDUSTRIAL CHEMICAL FEEDSTOCKS LSS, HSD17B14, HARS1 ALOX5 664/4885KDM4E 3627/4885MEN1 4704/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback